Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

Inhibitors of Bacterial DNA Synthesis

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enhanced trafficking of an inherited erythromelalgia Na<sub>V</sub>1.7 mutant channel at a physiological temperature.

Neurobiology of pain (Cambridge, Mass.)·2025

Same author

Targeted ubiquitination of Na <sub>V</sub> 1.8 reduces sensory neuronal excitability.

bioRxiv : the preprint server for biology·2025

Same author

Antimicrobial susceptibility of mastitis pathogens isolated from North American dairy cattle, 2011-2022.

Veterinary microbiology·2024

Same author

Comment on "Prevalence and antimicrobial susceptibility of Mycoplasma bovis from the upper and lower respiratory tracts of healthy feedlot cattle and those diagnosed with bovine respiratory disease".

Veterinary microbiology·2024

Same author

Compartment-specific regulation of Na<sub>V</sub>1.7 in sensory neurons after acute exposure to TNF-α.

Cell reports·2024

Same author

Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders.

Journal of the peripheral nervous system : JPNS·2023

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

Bacterial efflux pump inhibitors.

Barbara J Kamicker¹, Michael T Sweeney, Frank Kaczmarek

¹Pfizer Global R & D, MS, Groton, CT, USA.

Methods in Molecular Medicine

|April 26, 2008

Summary

Researchers developed a method to find new drugs targeting multidrug-resistant Gram-negative bacteria. This approach identifies compounds that block Resistance Nodulation Division (RND) efflux pumps, crucial for antibiotic resistance.

More Related Videos

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

Published on: February 17, 2014

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

Published on: February 17, 2014

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

Area of Science:

Microbiology
Pharmacology
Biochemistry

Background:

Multidrug-resistant Gram-negative pathogens cause significant hospital-acquired infections.
Increasing antibiotic resistance necessitates novel therapeutic strategies.
Resistance Nodulation Division (RND) efflux pumps are a key mechanism of resistance in Gram-negative bacteria, expelling various antibiotic classes.

Purpose of the Study:

To establish a multistep process for identifying inhibitors of RND-type efflux pumps.
To validate compounds that specifically target RND efflux pumps without general toxicity.

Main Methods:

Inhibition of ethidium bromide accumulation in bacterial cells (E. coli, H. influenzae).
Genetic and biochemical assays to confirm efflux pump specificity and rule out non-specific effects (e.g., antibacterial activity, membrane disruption).
Assessment of synergistic or antagonistic effects of inhibitors with antibiotics in liquid cultures, quantifying viable cells over 24 hours.

Main Results:

A validated multistep screening process was developed.
Compounds specifically inhibiting RND efflux pumps were identified.
Synergistic effects of identified inhibitors with antibiotics were confirmed, demonstrating potential for overcoming resistance.

Conclusions:

The described method effectively identifies specific inhibitors of RND efflux pumps.
This approach provides a pathway for developing new agents to combat multidrug-resistant Gram-negative infections.
Targeting RND efflux pumps offers a promising strategy to restore antibiotic efficacy.